Skip to main content
. 2013 Sep 11;8(9):e74067. doi: 10.1371/journal.pone.0074067

Table 1. Distribution of genotypes in ACS patients and controls.

Gene Polymorphism Genotype Frequency in ACS n(%) Frequency in control n(%) p value
P2RY1 1622 A>G GG 3 (0.03) 2 (0.03) 0.07
SNP1 AG 34 (0.39) 19 (0.25)
AA 51 (0.58) 56 (0.73)
A 68 (0.23) 12 (0.15) 0.02*
G (Ref.) 20 (0.77) 65 (0.85)
P2RY12 234 T>C TT 21 (0.24) 17 (0.22) 0.06
SNP2 CT 51 (0.58) 56 (0.73)
CC 16 (0.18) 4 (0.05)
T (Ref.) 46 (0.53) 45 (0.58) 0.5
C 42 (0.47) 32 (0.42)
742 T>C TT 4 (0.04) 6 (0.08) 0.26
SNP3 CT 11 (0.12) 15 (0.19)
CC 73 (0.83) 56 (0.72)
T 9 (0.11) 14 (0.18) 0.21
C (Ref.) 79 (0.89) 63 (0.82)
1622 C>T CC 27 (0.31) 74 (0.96) 0.05
SNP4 CT 51 (0.58) 2 (0.03)
TT 10 (0.11) 1 (0.01)
C (Ref.) 52 (0.60) 75 (0.97) 0.004*
T 36 (0.40) 2 (0.03)
2014 C>T CC 61 (0.69) 56 (0.73) 0.49
SNP5 CT 25 (0.28) 20 (0.26)
TT 2 (0.02) 1 (0.01)
C(Ref.) 73 (0.84) 66 (0.86) 0.79
T 15 (0.16) 11 (0.14)

SNP1, G > A allele, OR= 2.1, 95% CI= 1.1-4.03; SNP4, C>T allele, OR=20.05, 95% CI= 1.0-399

significant p values are marked as ‘* ’